SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122315
Filing Date
2019-04-26
Accepted
2019-04-26 16:07:05
Documents
2
Period of Report
2019-06-12
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY MATERIALS d711738ddef14a.htm DEF 14A 545686
2 GRAPHIC g711738g38f41.jpg GRAPHIC 8094
  Complete submission text file 0001193125-19-122315.txt   558118
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36500 | Film No.: 19771805
SIC: 2834 Pharmaceutical Preparations